Atherosclerosis is a slow, progressive disease, its most common manifestation and most severe consequence being coronary artery disease, one of the main causes of mortality and morbidity worldwide. The vast majority of cardiovascular deaths are caused by complications of atherosclerosis, most often being represented by the rupture of an unstable coronary plaque, regularly triggered by inflammation. A vulnerable plaque is characterized by a large, lipid-rich necrotic core, a thin fibrous cap with macrophage infiltration, and the presence of multiple specific biomarkers such as positive remodeling, irregular calcifications, and low attenuation visible with coronary computed tomography angiography (CCTA). Identifying biomarkers that could predict the risk of plaque rupture with high accuracy would be a significant advance in predicting acute cardiac events in asymptomatic patients, furthermore guiding treatment of patients with this disease. The main indication of noninvasive imaging is to identify patients at risk based on the presence or absence of symptoms that can be related to myocardial ischemia. The diagnostic objective is to confirm or to exclude the presence of coronary plaques. Coronary imaging in asymptomatic individuals is used to estimate the risk of future cardiac events through the identification of non-obstructive high-risk plaques. The possibility to monitor the evolution of vulnerable plaques via noninvasive imaging techniques, prior to the occurrence of an acute clinical event, is the main goal in plaque imaging. This manuscript will be focusing on recent advances of noninvasive imaging of vulnerable coronary plaques.
and the most severe consequence of atherosclerosis is coronary artery disease, which includes stable angina as well as acute coronary syndromes, making cardiovascular diseases one of the main causes of mortality and morbidity worldwide. 2 Given that it is projected to remain the leading cause of mortality, prevention strategies seem to be the only effective approach to reduce the incidence of this disease, improve mortality and morbidity, and reduce healthcare costs. 3, 4 Acute coronary syndromes represent the most severe outcome of atherosclerosis. The vast majority of cardiovascular deaths are caused by complications of atherosclerosis, most often being represented by the rupture of an unstable coronary plaque. 5, 6 Plaque destabilization is a complex biomechanical process that results from the cumulative effect of applied hemodynamical stresses, structural features, and biological processes that determine mechanical strength. 7, 8 
ThE CoNCEPT of vULNErAbLE PLAqUE -mArkErs of PLAqUE vULNErAbILITy
Acute coronary syndromes such as myocardial infarction and unstable angina, in most cases, are caused by a thrombus formed on an atherosclerotic plaque, plaque rupture being the base of fatal heart attacks in more than 75% of the cases. 6, 9, 10 A growing mass termed as a plaque is a build-up of lipids, fibrous tissue, and inflammation. 11 An atherosclerotic coronary plaque is vulnerable if it has a high risk of thrombosis in a short period of time and fast progression of stenosis. 9, 12 Research is showing that many patients with acute cardiovascular events do not have severely narrowed arteries; conversely, vulnerable plaques may show an eccentric deposit, buried in the artery wall, without blocking the blood flow through the artery. Therefore, severely stenotic coronary plaques do not always cause an acute major cardiac event. A vulnerable plaque is characterized by a large, lipid-rich necrotic core, a thin fibrous cap with macrophage infiltration, and the presence of multiple specific biomarkers such as positive remodeling, irregular calcifications, and low attenuation visible with coronary computed tomography angiography (CCTA). 5, 6, 13, 14 Lipoproteins are contained within the intima, and they seem to attract macrophages that secrete proteolytic enzymes, which leave behind a soft and destabilized lipid-rich cavity. This shows that inflammation has an important role in vulnerable plaque development. 15 If inflammation is associated with other factors, such as high blood pressure, it can lead to the cracking of the thin cap, spilling the contents of the vulnerable plaque into the bloodstream, causing the platelets to clump together and create a clot large enough to block an artery. The presence of a necrotic core is indispensable in plaque rupture; without it, there is no overlying fibrous cap to rupture. At the same time, a large necrotic core has a higher risk of rupture than a smaller one. 11, 16, 17 Studies have also found that vulnerable plaques are filled with various cell types that stimulate blood clotting. Vulnerable plaques can be divided into two groups: rupture-prone and erosion-prone. 11 The term plaque erosion is used when not even microscopic search can identify a plaque rupture. 1 Features of rupture-prone coronary plaques are a soft necrotic core covered by a thin fibrous cap (95% of ruptured caps are under 65 μm), a large plaque size, extensive remodeling, mild intraluminal stenosis, adventitial inflammation (post mortem examinations have revealed that ruptured caps show macrophage infiltration), spotty calcifications, and neovascularization (facilitating intra-plaque hemorrhage), many of these being detectable by imaging. 9, 14, [18] [19] [20] If vulnerable plaques could be identified before causing a major cardiac event, atherosclerosis would be a less dangerous disease. Identifying biomarkers that could predict the risk of plaque rupture with high accuracy would be a significant advance in predicting acute cardiac events in asymptomatic patients, furthermore guiding treatment of patients with this disease. The goal of this review is to focus on recent advances of noninvasive imaging of vulnerable coronary plaques. 12, 21 ThE CoNCEPT of bIomArkErs A biomarker can be defined as a characteristic that is objectively measured and evaluated, serving as an indicator of a pathogenic process, which is usually determined by laboratory measurements such as blood samples or urine, or may be a recording of a process. Key criteria are reproducibility, sensitivity, and specificity. Biomarkers can be used for disease diagnosis, therapeutic target validation, and patient selection and stratification. [21] [22] [23] [24] Recent studies have underlined the importance of identifying vulnerable plaques with a high risk of thromboembolic events. The main goal of noninvasive imaging should be to identify high-risk lesions and specific characteristics of plaque composition and plaque activity before any clinical event may occur. 20, 25, 26 
ImAgINg A vULNErAbLE PLAqUE
The main indication of noninvasive imaging is to identify patients at risk based on the presence or absence of symptoms that can be related to myocardial ischemia. The diagnostic objective is to confirm or to exclude the presence of coronary plaques. Coronary imaging in asymptomatic individuals is used to estimate the risk of future cardiac events through the identification of non-obstructive and high-risk plaques. 25 Imaging modalities can be divided into two groups: invasive and noninvasive, of which the invasive methodologies include angiography, intravascular ultrasound, and optical coherence tomography. 21 Noninvasive methodologies are ultrasound, magnetic resonance imaging (MRI), computed tomography angiography (CTA), and positron emission tomography (PET). [27] [28] [29] [30] ComPUTED TomogrAPhy ANgIogrAPhy (CTA)
Computed tomography has become one of the leading tools for diagnosing atherosclerotic disease, providing high spatial resolution of the coronary arteries. CT-based imaging biomarkers of a vulnerable plaque include: spotty calcifications, low density atheroma, active remodeling, and napkin-ring sign. 31 Computed tomography is widely used and very reliable, as it can detect higher-density calcified plaques, providing high sensitivity. On the other hand, disadvantages include the inability of differentiating between the different compositions of the non-calcified plaque areas, and the exposure to radiation. A study published in 2007 suggests its potential to monitor patients with atherosclerosis with statin therapy, showing that statin therapy can lead to important reduction of non-calcified plaque burden. 32 The coronary calcium score provides further information about cardiovascular risk, serving as an additional information to the Framingham risk score. 33, 34 However, vulnerable plaques are predominantly non-calcified, non-stenotic, and heterogeneous in composition. 33, 35 CT angiography with multi-detector row CT (MDCT) provides insights into the extent of atherosclerosis, allowing high-resolution imaging of the coronary artery stenoses and of the atherosclerotic plaques. 30, 36 MDCT has become the noninvasive imaging modality of choice for the detection of significant coronary artery stenosis. 33 A study published in 2009 found a significant correlation between the presence of instability markers detected with CT and future cardiac events, especially if three vulnerability markers, such as spotty calcification, active remodeling, and low-density atheroma, are present in the same plaque. 3, 37 CArDIAC mAgNETIC rEsoNANCE ImAgINg (mrI) Magnetic resonance is a noninvasive imaging tool. It has high resolution, providing functional characterization of the plaque and soft tissues based on proton density, perfusion, diffusion, and biochemical contrast. A full range of features that could represent plaque rupture are visible. 27 It can describe with high specificity and sensitivity the core with a thin fibrous cap that might be ruptured, calcifications, adventitia dimensions, and intra-plaque hemorrhage and thrombosis. 27, 30, 38 MRI is showing great promise to study atherosclerosis in the coronary arteries as well as in the carotid arteries, as demonstrated in several clinical studies. The exploration of MRI applications is still evolving, especially with the improvement of different contrast agents for the assessment of molecular and cellular components of atherosclerosis. 27, 39 With the development of special contrast agents that target some of the molecular markers of atherosclerosis and cellular components of high-risk plaques such as macrophages and endothelial adhesion molecules (for vascular inflammation), fibrin, and plaque neo-vessels, MRI has become an excellent tool to monitor atherosclerotic plaque vulnerability and overcome some of its limitations. 30, 40, 41 Cell adhesion molecules are involved in the early stages of atherosclerosis, because of their involvement in inflammation. A thrombus in the atherosclerotic plaque can be a target of molecular imaging, being a late-stage marker for atherosclerosis. 42 The direct imaging of thrombosis has become possible with fibrin-binding molecular contrast agents. 30, 43 Since intra-plaque hemorrhage is considered one of the main contributors to plaque destabilization, MRI has been recently used to assess the anti-angiogenic efficacy of drugs acting on neoangiogenesis and the reduction of plaque vulnerability. 30, 44 
PosITroN EmIssIoN TomogrAPhy
Positron emission tomography with F-18-fluorodezoxyglucose (FDG) is a noninvasive imaging technique with high sensitivity that helps to study human physiology and provides a measure of metabolic and functional activity based on the detection of positron-emitting radiopharmaceuticals. 30, 45 The main limitations of PET are the poor resolution, the requirement of specific radioactive tracers, and the limited availability and lengthy scan times. 21, 45 FDG-PET imaging has been recently used to study the mechanisms of atherosclerosis. Being a glucose analog, FDG is thought to be an indicator for the inflammatory process, since macrophages have a higher glucose metabolism compared to the plaque and healthy tissue. Studies have shown that there is a strong association between FDG uptake and macrophage deposit. Furthermore, it positively correlates with several circulating inflammatory biomark-ers such as metalloproteinase, which degrades the cellular matrix in the plaque. [45] [46] [47] [48] In conclusion, we can state that FDG uptake in vulnerable atherosclerotic lesions can have a significant clinical importance in the prevention of future cardiac events.
hybrID TEChNIqUEs
Multiple hybrid imaging techniques are available, which can target the vascular system, such as PET/CT or PET/ MRI. PET has a relatively low spatial resolution, making it necessary to use other imaging techniques such as CT or MRI. Hybrid PET/CT makes it possible to measure the functional and structural characteristics of atherosclerosis, where FDG uptake suggests atheromatous lesions with active inflammation. On the other hand, CT identifies chronic calcification and may also detect the effect of drug treatment in correlation with inflammatory biomarkers. 45, [48] [49] [50] Hybrid PET/MRI has great potential for cardiovascular imaging. The morphological features of carotid plaques, such as lipid deposits, luminal irregularities, and the inflammatory processes shown on PET, demonstrate a strong association with the risk of cardiac events. Furthermore, inflammation may be associated with a higher number of vulnerable characteristics within the atheroma, emphasizing the theory that plaque inflammation and its phenotypical structure are closely linked. With the development of new imaging technologies and the introduction of combined PET and MRI scanners, it is possible to combine the positive and useful facets of each imaging modality in order to achieve the best method for the assessment of plaque morphology. [50] [51] [52] CoNCLUsIoNs Atherosclerosis is a generalized disease characterized by a systemic inflammatory response that will trigger the development and progression of vascular plaques with a multifocal character. The identification of atherosclerotic lesions before any clinical events allows the introduction of appropriate strategies to prevent plaque progression and help its regression. The possibility to monitor vulnerable atheromatous lesions by using noninvasive imaging, prior to the occurrence of an acute clinical event, is the main goal in plaque imaging. Investigation techniques need to be noninvasive, reliable, inexpensive, and not harmful if multiple examinations are necessary over time. Noninvasive imaging technologies hold great promise that well-established diagnostic technologies can be developed, help-ing to evaluate the effectiveness of therapy and to identify high-risk patients.
